Table 2. Baseline characteristics of enrolled patients.
| Parameters | Gout (n = 242) | Control (n = 280) | P value |
|---|---|---|---|
| Age, yr | 55.0 (45.0–63.0) | 45.0 (41.0–53.0) | < 0.001 |
| Disease duration, yr | 7.0 (3.0–10.0) | - | - |
| Onset age of disease, yr | 47.0 (38.0–56.0) | - | - |
| Height, cm | 170.0 (168.0–174.0) | - | - |
| Weight, kg | 73.0 (65.3–80.0) | - | - |
| Body mass index, kg/m2 | 25.3 (23.6–26.7) | - | - |
| Uric acid, mg/L | 6.4 (5.1–7.6) | - | - |
| Current medications, No. (%) | - | - | |
| NSAIDs | 123 (50.8) | ||
| Colchicine | 146 (60.3) | ||
| Allopurinol | 154 (63.6) | ||
| Benzobromarone | 61 (25.2) | ||
| Corticosteroid | 85 (35.1) |
Data were expressed as with interquartile range (IQR) for continuous variables and number (%) for categorical variables.
NSAIDs, non-steroidal anti-inflammatory drugs.